News

Harvard Bioscience to Present Cutting-Edge Neuroscience Innovations

Harvard Bioscience to Present Cutting-Edge Neuroscience Innovations

Innovative Solutions for Neuroscience at SfN 2024

Harvard Bioscience, Inc. (NASDAQ: HBIO) is poised to showcase its latest technological advancements at the highly anticipated Society for Neuroscience (SfN) 2024 Annual Meeting. This prominent event, which will take place from October 5 to 9 in Chicago, will highlight several groundbreaking products designed to enhance neuroscience research.

Revolutionary Mesh MEA™ Microelectrode Array

Exploring Electrophysiology Inside Organoids

At the forefront of the display will be the MCS™ Mesh MEA™ organoid platform, a state-of-the-art microelectrode array designed to revolutionize how researchers study neural dynamics. Unlike traditional technologies, this new platform captures real-time electrophysiological signals directly from within organoids. This capability opens up exciting new avenues for understanding complex brain disorders.

The Mesh MEA platform is currently being assessed in select test sites aimed at neurological and cardiac research, alongside applications in safety pharmacology and toxicology. Early adoption shipments have already begun, with full-scale production expected by mid-2025.

Showcasing SoHo™ Implantable Telemetry

Real-Time Data Collection for Small Animal Models

Harvard Bioscience will also present its innovative SoHo implantable telemetry system. This real-time telemetry solution is tailored for small animal models, integrated seamlessly with the Ponemah™ data management platform. The SoHo system empowers users to efficiently collect, analyze, and report on findings from multiple small animal subjects housed together, enhancing the reliability and precision of behavioral and neurophysiological studies.

This system facilitates extended data collection periods, which is pivotal for longitudinal research, allowing scientists to gather deeper insights into the neurological phenomena they are studying.

VivaMARS™ – A Comprehensive Activity Monitoring System

Enhancing Behavioral Testing Efficiency

The VivaMARS system will also be showcased, providing users with a highly automated platform for behavioral testing in various research contexts. This includes neuropharmacology and safety-related studies. The VivaMARS system not only enhances the quality and efficiency of these tests but also significantly reduces operational costs and test cycle durations. During the conference, insights derived from collaboration with a key customer will be shared to illustrate the system's impact.

Comprehensive Neuroscience Research Solutions

Expanding Product Offerings

The exhibition will highlight an array of technologies, including the brand-new Heka™ patch clamp amplifiers, which are designed to refine the recording of rapid events, such as ion channel dynamics. Harvard Bioscience's offerings extend to a comprehensive suite for both in vitro and in vivo research, demonstrating their commitment to supporting the global neuroscience research community.

Exciting Expo at SfN 2024

Visitors can experience these innovative solutions firsthand at booth #925 during the conference, where Harvard Bioscience representatives will be eager to discuss the latest developments in neuroscience technology. The McCormick Place Convention Center will host this event, and the team will be available daily from 9:30 a.m. to 5:00 p.m. CDT starting Sunday.

About Harvard Bioscience

Harvard Bioscience, Inc. is dedicated to advancing life sciences with its range of technologies, products, and services. It serves a diverse customer base, including prestigious academic institutions and leading pharmaceutical companies worldwide. With operations across North America, Europe, and China, Harvard Bioscience employs both direct and distributed sales channels to reach customers globally.

Frequently Asked Questions

What technologies will Harvard Bioscience present at SfN 2024?

They will showcase the Mesh MEA microelectrode array, SoHo implantable telemetry, and VivaMARS activity monitoring system.

When is the Society for Neuroscience Annual Meeting?

The meeting will take place from October 5 to 9 in Chicago.

What is the Mesh MEA platform designed for?

This platform captures neural signals from organoids in real time, helping researchers study complex brain dynamics.

What benefits does the SoHo telemetry system provide?

The SoHo system offers real-time data collection for small animal models, enhancing experimental reliability and duration.

How does the VivaMARS system improve behavioral testing?

It provides an efficient and automated platform that reduces costs and test times while enhancing data accuracy.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading

Top 5 Most Recently Viewed Articles

You Call The Play Inc. (YCTP) Leads with Integrity in Betting

Updated Category News Views 154

Understanding You Call The Play Inc. (YCTP)'s Initiative In an important move for the sports betting landscape, You Call The Play Inc. (YCTP) has recently unveiled a national licensing plan and a groundbreaking measure called the Safe Bet Overlay™. This initiative is designed to foster trust and transparency within an industry that continues to grow rapidly across the...

Continue Reading
Cash for Houses Pro Earns Stellar Reputation with 5-Star Reviews

Updated Category News Views 167

Cash for Houses Pro Achieves 5-Star Reviews Cash for Houses Pro is celebrating their recent success in receiving numerous 5-star reviews on Google for their service known as 'Sell Your House Fast In Tampa FL For Cash'. This recognition reflects the team's dedication to providing homeowners with a seamless and stress-free home selling experience. About Cash for Houses Pro...

Continue Reading
Pfizer's Potential Transformation Following Starboard Investment

Updated Category News Views 77

Pfizer's Revised Price Target and Market Standing Recently, CFRA, a prominent financial research firm, elevated its price target for Pfizer Inc. (NYSE:PFE) from $30.00 to $31.00 per share. This adjustment comes while maintaining a 'Hold' rating on the stock, suggesting a careful observation of its market performance. The current price target reflects a valuation based on...

Continue Reading
Equinox Gold's Impressive Q2 Results Spark Stock Surge Today

Updated Category News Views 103

Equinox Gold Delivers Strong Quarterly Performance Equinox Gold Corp. EQX has seen its shares rise significantly following the release of its second-quarter financial results, which exceeded market expectations. Investors reacted favorably, driving the stock up on Thursday. Financial Highlights from the Quarter In the latest quarterly report, Equinox Gold announced...

Continue Reading
Investor Insights on Alexandria Real Estate Equities' Legal Challenges

Updated Category News Views 219

Understanding the Alexandria Real Estate Equities, Inc. Lawsuit Investors have an important opportunity arising from a lawsuit against Alexandria Real Estate Equities, Inc. (NYSE: ARE). A national shareholder rights litigation firm has initiated a class action alleging the Company has violated various securities laws. This situation has caught the attention of many...

Continue Reading